Paracentesis for malignant ascites is usually performed as an in-patient procedure, with a median length of stay (LoS) of 3–5 days, with intermittent clamping of the drain due to a perceived risk of ...

A new low-flow ascites pump significantly reduced paracentesis frequency in patients with a contraindication to transjugular intrahepatic portosystemic shunt, or TIPS, according to a recently ...

Please provide your email address to receive an email when new articles are posted on . HONOLULU — Researchers found that patients with spontaneous bacterial peritonitis who underwent repeat ...

Aug. 23, 2004 — Large-volume paracentesis performed by gastrointestinal endoscopy assistants in an outpatient setting is safe and efficient, even in patients with marked thrombocytopenia or prolonged ...

To the Editor: In the article, "Hemodynamics in the Cirrhotic Patient during Paracentesis." which appeared in the March 2 issue of the Journal, Knauer and Lowe report on circulatory changes occurring ...

2.1 The PeritX peritoneal catheter drainage system (BD) is intended for use in the management of treatment-resistant, recurrent malignant ascites (accumulation of fluid in the peritoneal cavity) in ...

The Ascites may be due to cancer like ovarian malignancy. Cirrhosis of liver is the most common cause and the underlying liver disease is to be addressed first. The patient has to be counselled to ...

HERNIA is known to be more frequent among patients with cirrhosis of the liver, especially with ascites, than among those without liver disease. Chapman et al. 1 reported a rate of 10 per cent in 58 ...

SANTA MONICA, CA / ACCESSWIRE / October 22, 2019 / BioVie Inc. (BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for liver disease, announced today that ...

NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Martin Pharmaceuticals, a clinical-stage pharmaceutical company targeting complications of advanced liver disease, today announced that results from its DREAM ...

The sponsor submitted a new cost analysis based on a decision tree model with an embedded Markov model. This model evaluated the costs per patient and system impact of the PeritX peritoneal catheter ...